ArticleJournal of the Endocrine Society2026
Sex- and Lineage-Dependent Transgenerational Effects of Vinclozolin and Flutamide on Rat Development and Behavior.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Vinclozolin (VIN) is an agricultural fungicide that acts as an endocrine-disrupting chemical (EDC), primarily through its anti-androgenic actions. Developmental exposure to VIN is linked with reproductive and neurodevelopmental alterations; furthermore, VIN was the first EDC identified as causing heritable epigenetic transmission across generations. The present study provides a more detailed and comprehensive look into the developmental and transgenerational behavioral effects of VIN exposure in rats, with the experiment designed to investigate the influence of sex differences and parental lineage (maternal, paternal). Specifically, dams were exposed to either the vehicle (DMSO; negative control), VIN (100 mg/kg), or flutamide (FLUT; 1 mg/kg), the latter an anti-androgenic compound used as a positive control for the anti-androgenic effects of VIN. Developmental measures, anxiety, and social tests were conducted on males and females from the F1 (direct prenatal exposure) and F3 (ancestral exposure through epigenetic inheritance) generations. Generally, effects were sexually dimorphic, lineage-specific, and differed between FLUT and VIN, pointing to different mechanisms of the chemicals. More behavioral effects of VIN emerged at the F3 generation's paternal lineage compared to the F1 generation. Overall, this study provides more detailed insight into the transgenerational effects of a high dose of VIN exposure and suggests future inquiry into the mechanisms of action of the EDC, specifically as it pertains to its differences from FLUT and its differing effects on lineage, sex, and generation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.